about
Estrogen receptor alpha is a novel marker expressed by follicular dendritic cells in lymph nodes and tumor-associated lymphoid infiltrates.Modulation by cytokines of glucocorticoid action.O-Glycosylation of human sex hormone-binding globulin is essential for inhibition of estradiol-induced MCF-7 breast cancer cell proliferation.The androgen receptor CAG repeat: a modifier of carcinogenesis?Pituitary lesions in breast cancer patients: A report of three cases.Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer.Emerging molecular therapies of advanced thyroid cancer.The pan-histone deacetylase inhibitor LBH589 (panobinostat) alters the invasive breast cancer cell phenotype.Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo.Valproic acid restores ER alpha and antiestrogen sensitivity to ER alpha-negative breast cancer cells.Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure.Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells.Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines.High energy shock waves activate 5'-aminolevulinic Acid and increase permeability to Paclitaxel: antitumor effects of a new combined treatment on anaplastic thyroid cancer cells.Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells.Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells.Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells.Sex steroid binding protein is a negative modulator of estrogen-induced breast cancer cell growth.Meningiomas after cranial radiotherapy for childhood cancer: a single institution experience.Control of the membrane sex hormone-binding globulin-receptor (SHBG-R) in MCF-7 cells: effect of locally produced SHBG.GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution.The receptor-mediated action of sex steroid binding protein (SBP, SHBG): accumulation of cAMP in MCF-7 cells under SBP and estradiol treatment.Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.The receptor for human sex steroid binding protein (SBP) is expressed on membranes of neoplastic endometrium.Doxorubicin-Loaded Nanobubbles Combined with Extracorporeal Shock Waves: Basis for a New Drug Delivery Tool in Anaplastic Thyroid Cancer.Sex steroid binding protein receptor (SBP-R) is related to a reduced proliferation rate in human breast cancer.MCF-7 cell progesterone receptor (PGR) is additionally modulated by sex steroid binding protein (SBP) and its membrane receptor (SBP-R) through cAMP and PKA.Altered expression of androgen-receptor isoforms in human colon-cancer tissues.Extracorporeal shock waves modulate myofibroblast differentiation of adipose-derived stem cells.The additionally glycosylated variant of human sex hormone‐binding globulin (SHBG) is linked to estrogen‐dependence of breast cancerHistone Deacetylase Inhibition Modulates E-Cadherin Expression and Suppresses Migration and Invasion of Anaplastic Thyroid Cancer CellsOxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cellsvia cyclic adenosine monophosphate and protein kinase ASomatic alterations of the androgen receptor CAG repeat in human colon cancer delineate a novel mutation pathway independent of microsatellite instabilityEstradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG)Binding of sex steroid binding protein to plasma membranes of human testisBiological relevance of the interaction between sex steroid binding protein and its specific receptor of MCF-7 cells: Effect on the estradiol-induced cell proliferationHormonal and clinic evaluation of patients with moderate body hair growthReceptor for sex steroid-binding protein of endometrium membranes: solubilization, partial characterization, and role of estradiol in steroid-binding protein-soluble receptor interaction
P50
Q33193291-15AFEACE-1751-4F8D-90F5-457FB09486DAQ33692675-DC760D7C-0EF3-4B90-A217-F73DA517F216Q34130969-87DF2240-6D46-4D1C-B5C8-DFD0325A3ED1Q34772530-3903BC45-3BF0-4928-95C3-DC86C524924BQ35758971-E844EA11-2C66-4CB6-B06C-BCDA18E52D37Q37601054-8E0DD2F2-F56A-4072-BEC8-F4D234F17320Q37696635-22A9269E-A972-43A6-85C6-12136AF9063EQ39040551-D199B49F-DDCD-4E34-97CF-BD1AD668872FQ39175368-78CE27D3-9B08-4079-A563-FFA6A60F093CQ39576722-410D86E3-01DB-4639-86BD-64C4875CD62FQ39796457-4DCF489A-64B4-4C24-AC59-60EF1CFBE39CQ39988197-1649052A-2AC2-4360-AF9A-85DB69B55E53Q40051087-64CEEDEF-3A63-402E-AFB7-1D98B3E6657FQ40072387-7163CADA-4F34-4222-8F35-26AE7FEE1CB8Q40168104-B925A2FC-5DB4-4949-BFDB-D2D6F4D72C83Q40211424-5B4985FA-05B4-427A-8A25-A4476EC8BF09Q40300902-69EF2D51-1C85-49EE-9E48-405F23C52594Q40483365-30CCE1BD-D2A4-4F20-9333-014579ABCD2FQ40592037-26819462-3D59-4E2E-85D8-2AC85ED5AFF1Q40999417-19647EB2-1AD5-4B8D-B43A-E4ACC8279D7CQ41547461-CD9C6443-19B1-4A39-A53C-1F7F6BBD5739Q42456335-6902224F-B83D-40A5-9249-D6E68F1BD93DQ42467636-C543B8A4-70D9-470B-AADC-D12C22CA9EC0Q42484317-E5D0989C-8ADF-4FD8-A167-7561141386E8Q43668998-347460B7-370E-4476-9D05-355FFF87AF38Q43894043-3109BA99-7FB5-423B-A11F-1676F08F8D2BQ50204367-499FD1B6-5AB2-4F21-B869-6040464A5E89Q50968589-BAAE166B-92C6-4E48-B884-22868E073439Q51030394-9AD547B4-F8F8-4E3B-AAFF-0FFFCC4E43E8Q53411360-65C66088-48C4-4998-A71D-5CDFED9A66A5Q53800156-C78AA152-181E-4B29-80B3-6E291409E815Q57961988-073EDD7B-D868-497A-A130-3C59B26F7681Q59836005-5EA18DA0-15E7-49B2-B5DE-8579182E6C87Q60286418-E3536EF0-ECB7-4CAD-A66C-A5DB889CC7DCQ61449459-88476D5E-9F94-4DCC-BB6C-0A19362A84BDQ61449462-5BCB59CD-559C-4585-AD3D-98F1AD8EF4E9Q61449488-1F862DEA-247C-4345-AD8C-12F5AD1B0A51Q61449496-56E5CD11-85A3-482E-B96A-C5BF68C97C2BQ61449500-7BB2DE26-E2BC-4E98-96CD-7AF8B22A53F1Q61449509-53A79AAD-CBFD-4752-8D99-3DE9461C5BA2
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nicoletta Fortunati
@ast
Nicoletta Fortunati
@en
Nicoletta Fortunati
@es
Nicoletta Fortunati
@nl
Nicoletta Fortunati
@sl
type
label
Nicoletta Fortunati
@ast
Nicoletta Fortunati
@en
Nicoletta Fortunati
@es
Nicoletta Fortunati
@nl
Nicoletta Fortunati
@sl
prefLabel
Nicoletta Fortunati
@ast
Nicoletta Fortunati
@en
Nicoletta Fortunati
@es
Nicoletta Fortunati
@nl
Nicoletta Fortunati
@sl
P1053
K-3081-2016
P106
P21
P31
P3829
P496
0000-0001-8069-9621